Navigation Links
BioSpecifics Technologies Corp. to Present at Rodman & Renshaw 12th Annual Healthcare Conference
Date:9/8/2010

LYNBROOK, N.Y., Sept. 8 /PRNewswire/ -- BioSpecifics Technologies Corp. (Nasdaq: BSTC), a biopharmaceutical company developing first in class collagenase-based products, today announced that BioSpecifics' President, Tom Wegman, will present at the upcoming Rodman & Renshaw 12th Annual Healthcare Conference on Wednesday, September 15, 2010, at 9:35am EDT.

A live webcast of the presentation can be accessed under "Calendar of Events" in the Investor Relations section of the Company's website at http://www.biospecifics.com, or you may use the link: http://www.wsw.com/webcast/rrshq18/bstc.

About BioSpecifics Technologies Corp.BioSpecifics Technologies Corp. is a biopharmaceutical company that has developed injectable collagenase for eleven clinical indications, three of which include: Dupuytren's contracture, Peyronie's disease, and frozen shoulder (adhesive capsulitis). Its strategic partner Auxilium markets XIAFLEX in the U.S. for the treatment of Dupuytren's contracture. Pfizer, Inc. is responsible for marketing XIAFLEX in Europe. More information about BioSpecifics may be found on its website at http://www.biospecifics.com. Contact:BioSpecifics Technologies Corp.Thomas L. Wegman, President(516) 593-7000thomas_wegman@biospecifics.com
'/>"/>

SOURCE BioSpecifics Technologies Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related biology technology :

1. BioSpecifics Technologies Corp. Reports Second Quarter 2008 Financial Results
2. BioSpecifics Technologies Corp. Buys Down Royalties for Peyronies Disease
3. BioSpecifics Technologies Corp. Announces Appointment of Dr. Matthew Geller to Board of Directors
4. BioSpecifics Technologies Corp. to Present at Piper Jaffray 20th Annual Health Care Conference
5. BioSpecifics Technologies Corp. Announces Listing on NASDAQ Global Market
6. BioSpecifics Technologies Corp. Reports Fourth Quarter and Full Year 2008 Financial Results
7. BioSpecifics Technologies Corp. Announces FDA Acceptance of Biologics License Application With Priority Review for XIAFLEX(TM) for the Treatment of Dupuytrens Disease
8. BioSpecifics Technologies Corp. Reports First Quarter 2009 Financial Results
9. BioSpecifics Technologies Corp. Added to Russell 3000 and Russell 2000 Indexes
10. BioSpecifics Technologies Corp. to Present at CapStone Investments Third Annual Small-Cap Investor Conference
11. BioSpecifics Technologies Corp. to Host Conference Call to Report Second Quarter 2009 Financial Results on August 12, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/31/2015)... Angeles, CA (PRWEB) March 31, 2015 ... and Professors from the top U.S and International Medical ... share their latest research on the application of stem ... diseases. The symposium is organized and funded by the ... independent nonprofit that has been convening intimate meetings of ...
(Date:3/31/2015)... (PRWEB) March 31, 2015 Today, Cryos ... official relocation of their U.S. facilities and inventory from ... 25 years of experience, Cryos’ relocation is a reflection ... The move to Orlando was completed during the first ... official opening taking place on April 6. The new ...
(Date:3/31/2015)... OH (PRWEB) March 31, 2015 Diasome ... its licensor, SDG, Inc., that a United States patent ... liver-targeted insulin therapy. , Entitled “Lipid Construct ... covers composition of matter claims related to the use ... system for enabling injected insulin to more effectively reach ...
(Date:3/31/2015)... 31, 2015 Lighthouse Information Systems, ... operations in California, Oregon, Washington and clients across ... Merger and Acquisition (M&A) Integration Services offering, effective ... Client Services and M&A Integration Practice Leader at ... vast majority of M&A initiatives fail to achieve ...
Breaking Biology Technology:Sight Restoration Through Stem Cell Therapy - Subject of June Symposium of Experts 2Cryos International Completes Groundbreaking Sperm Migration to Orlando, Florida 2Diasome Pharmaceuticals, Inc. Announces Notice of Allowance from US PTO for Liver Targeting System for Insulin 2Lighthouse Information Systems, Inc., Announces Addition of M&A Integration Services 2
... announced today that Mr. Paulo F. Costa has been elected ... Costa is the former President and Chief Executive Officer of ... experience in operations and commercialization in the pharmaceutical industry, Mr. ... , "We are privileged to have Mr. Costa join MacroGenics, ...
... Additions to the Human Protein Atlas, available exclusively through Sigma-Aldrich, ... Antibodies , , ST. LOUIS, June 23 Sigma-Aldrich ... over 2,300 antibody additions to its Prestige Antibodies(R) powered by ... the total number of highly validated antibodies to over 6,100. ...
... VIENNA, Austria, June 23 MIG Fonds and ... & Private Equity Award,competition, hosted by the industry magazine Boerse-Express ... venture fund and the Austrian biotechnology company as well as ... Last Tuesday MIG Fonds and AFFiRiS ...
Cached Biology Technology:Paulo F. Costa Joins MacroGenics Board of Directors 2Paulo F. Costa Joins MacroGenics Board of Directors 3Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM) 2Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM) 3Sigma-Aldrich and Atlas Antibodies Announce 2,300 New, Highly Validated Prestige Antibodies(RM) 4AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS 2AFFiRiS AG: 1st Place in Venture Capital & Private Equity Awards for MIG Fonds and AFFiRiS 3
(Date:3/30/2015)... Research and Markets ( http://www.researchandmarkets.com/research/lc9bnl/global_gesture ) ... Recognition Market in Automotive Sector 2014-2018" report to ... Gesture Recognition market in Automotive Sector to grow at ... Gesture recognition is the ability of a device ... individual. Gesture recognition technology can be 2D-based or 3D-based. ...
(Date:3/26/2015)... The Granite Club, Canada,s ... announced it has implemented a state-of-the-art access and security ... and staff, while restricting access to authorized users only. ... IMID Access system because it has the perfect combination ... in addition to unparalleled security," said James DiRenzo ...
(Date:3/24/2015)... 24, 2015 Research and Markets ( ... "Global Iris Recognition Market 2015-2019" report to their ... Recognition market to grow at a CAGR of 23.5 ... covers the present scenario and the growth prospects of ... To calculate the market size, the report considers the ...
Breaking Biology News(10 mins):Global Gesture Recognition Market in Automotive Sector Report 2015 - Growing Number of Partnerships 2Granite Club First Private Club in North America to Implement FST Biometrics Secure Access Solution, as Part of Multi-million Dollar Expansion 2Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2
... high-traffic waters near the Three Gorges Dam in China, ... today. Scientists from Woods Hole Oceanographic Institution (WHOI) and ... new light on this species, critical sense of hearing ... underwater construction. "We want to understand how they ...
... crushing force and volcanic heat to forge diamonds, researchers ... to cheaply make nanodiamonds on a lab bench at ... are formed directly from a gas and require no ... for many uses in technology and industry, such as ...
... scientists at the University of Liverpool has found ... present in every infectious disease model would improve ... modelling plays a central role in planning for ... how they might progress and guiding and informing ...
Cached Biology News:Seeing in the dark 2Seeing in the dark 3CWRU makes nanodiamonds in ambient conditions 2CWRU makes nanodiamonds in ambient conditions 3CWRU makes nanodiamonds in ambient conditions 4Study explores the role of uncertainty in infectious disease modelling 2
... BAC (100+kb), fosmid (40kb), and large plasmid ... any othe BAC vector. On command 20-50 ... easy recombinant DNA purification. Available with blue-white ... vectors for the highest insert stability. Kits ...
MAGP-2 (C-19)...
Laminin gamma-2 (G-16)...
... 100 slides. Immunocytochemistry.Sample types: suitable for ... labeling.Recommended cell number: 10 6-107 ... at 2-8 C (except DAB: -15 ... & Cellular Assays, Assays . Specific ...
Biology Products: